Medicina clinica
The most recent articles from:
November 2019
-
Multicenter Study
Antibody responses to influenza vaccine in patients on biological therapy: Results of RIER cohort study.
Influenza vaccine is recommended for patients with autoimmune inflammatory rheumatic diseases who receive biological therapy. To evaluate if biological therapy impairs immunization after seasonal influenza vaccine. ⋯ Among the patients on biological therapy vaccinated against influenza, anti-TNF therapy was identified as a predictive factor of final seropositivity. Rituximab presented a lower rate of final seropositivity, which could be increased with an accurate administration schedule.